Integrated Treatment of Prostaglandin E1 and Angiotensin-Converting Enzyme Inhibitor in Diabetic Kidney Disease Rats: Possible Role of Antiapoptosis in Renal Tubular Epithelial Cells.

MLA

Mou, Yaru, et al. “Integrated Treatment of Prostaglandin E1 and Angiotensin-Converting Enzyme Inhibitor in Diabetic Kidney Disease Rats: Possible Role of Antiapoptosis in Renal Tubular Epithelial Cells.” DNA & Cell Biology, vol. 37, no. 2, Feb. 2018, pp. 133–41. EBSCOhost, https://doi.org/10.1089/dna.2017.3690.

APA

Mou, Y., Zhang, Y., Guo, C., Zhao, J., Zhang, Z., Zhou, X., Dong, J., & Liao, L. (2018). Integrated Treatment of Prostaglandin E1 and Angiotensin-Converting Enzyme Inhibitor in Diabetic Kidney Disease Rats: Possible Role of Antiapoptosis in Renal Tubular Epithelial Cells. DNA & Cell Biology, 37(2), 133–141. https://doi.org/10.1089/dna.2017.3690

Chicago

Mou, Yaru, Yaqin Zhang, Congcong Guo, Junyu Zhao, Zhongwen Zhang, Xiaojun Zhou, Jianjun Dong, and Lin Liao. 2018. “Integrated Treatment of Prostaglandin E1 and Angiotensin-Converting Enzyme Inhibitor in Diabetic Kidney Disease Rats: Possible Role of Antiapoptosis in Renal Tubular Epithelial Cells.” DNA & Cell Biology 37 (2): 133–41. doi:10.1089/dna.2017.3690.